Member Info for Scoobydoo321

Dropped below IPO price - for a quality outfit like this - can not be right!

Bigboot - you are not missing something - I've had this stock for a few months - bought entry level at 212p - It's boring, spread's wide, low margins + exposed to Brexit (hence the big fall today which allowed me to get in to buy more).
As stockopedia says - The Company's principal activities are the provision of haulage services, waste transportation, mineral import, mining and processing, together with specialist earthworks and related activities. Its segments include Coal Distribution, Industrial Services, Logistics and Specialist Earthworks - zzzzzzzzzzzz
But it's got
- NAV 403p
- January high was around 320p
- latest TU was trading as expected
- Mr Thompson in Aug 20 - says The board has just declared a maintained final dividend of 4.5p a share (ex-dividend: 17 September), and anticipates declaring a special dividend of 12p along with the final in the 2020/21 financial year. Analysts are pencilling in a total payout of 20p. - Very very nice divies.
So thumbs up.

I bought into this co. coz of this
https://www.itv.com/news/2020-11-21/chancellor-rishi-sunak-to-announce-500-million-package-to-support-mental-health-services
Surely some of this is going to seep through.
Also, their web portal for youth's mental health appears to be promoted by a lot of schools. I noticed their portal via my elder son's headmaster's letter. Solid work here for the youth.

Mt Sinai commercial officer gets interviewed.
https://kantarobio.com/83772-2/
Kantaro kit is right on the money. Thus, doesn't appear to be a question of when this will be used but to what extent. Based on the video - kantaro is excellently placed to become the defacto standard for worldwide antibody testing and RENX gets 10%

In saying that, the prevalent trend for their main clientele base, i.e. blue collar staff is to buy insurance - more than ever. Given the uncertainty and covid health risks presented people are naturally more risk averse particularly when they are the breadwinner of the family. Hats off to PGH for meeting all covid claims. Real stamp of trust there.
In addition, with virtual visits with staff, it's made it easier, cheaper and more efficient for PGH staff to service their clients - making a positive from a negative.

Buys and Sells are all wrong. The whole sea of red is incorrect. Best to look at the trade price to determine which one is the ask price vs offer price

Nice one sharehunter.

Appears as if RBGP, just will not go down anymore given current sentiment _ Ive been waiting weeks and weeks for it to see if SP will fall further but not to be, so I've decided to take a stake just in case they release a TU ( Nicola Foulston is heavily invested into the company so I'm sure she would seek to maintain the SP). Ok - so this is not a SYME or IQAI but if it can provide 15-20% upside with 6 weeks of waiting with minimal downside - me in !

I suppose

CON
- "Post the lockdown, face-2-face meeting were stopped resulting in only £2.1m of new business being written versus £4.6m in H1 2019 but with 60-70% written pre the lockdown. This decline will reduce future premiums / profits and the 2H number will be ‘even lower’. " I can live with this as the company sorts itself out - it's got tons of liquidity to do so.
- may take a little time to recover business that was deferred due to covid lockdown in H1
- Brexit no-deal concerns? I suppose if companies start slashing their workforce and blue collar staff are unfortunate to bear the brunt of Brexit they may be impacted negatively.

Overall for the risk:rewards, I'm in.

Totally agree Johnny.
Cheaper than March 2020 levels! What's going on! Positive update during summer ; SP 300p , now SP around 200p mark - are you serious!
- They got plenty of cash (even after taking into consideration solvency rules) ;
- 50% down from pre-covid levels (even more if you look back to 2018 and beyond) so tons of upside ;
- H1 was affected by lockdown but they learnt how to operate with virtual visits with customers.
- clientele base being primarily blue-collar staff will always need company insurance + perks
- I thought I heard that they have just acquired a big name supermarket chain - to be announced they said (or am i imagining things?) - this could boost up their numbers big time.
- Their App was extensively used by the company to communicate with their staff = stickiness for the future = less churn from existing staff / company
- Alliance with Sage - early times - but could be a new nesting ground for new growth
- CEO says they are ahead of last year's trading and this is during covid !!! So why is the SP so low!
- historic divies were 10% yield - ok - may not get that high but still - likely to be decent
- appointment of Martin Bennett as a non-executive director from January 1, 2021 - formerly CEO of Homeserve (ftse 100 co.) - good addition - I am sure will add beef to the company's strategy and way forward.
- the CEO recently bought £10,000 worth of shares on the 16/11, adding to her sizeable holding. On the 25/11 a RNS was published highlighting other insider purchases, one being the interim CFO. If the frugal CFO buys, it's likely that the stock is pretty robust.
- management focus on growth - CEO is fairly newish + new ‘growth driven’ Chairman is to be announced shortly, replacing the existing one at the next AGM having been appointed in 2016 but joined the PLC in 2013. The Deputy Chairman is also stepping down after 20 years of service but is to remain on the insurance board.
- Future meetings with customers could be more leaning towards virtual = cheaper + efficient for PGH staff + better customer service which means higher stickiness of customers.
PE current is 8 + ROCE is > 20% - excellent
Excellent staff culture - I checked out Glassdoor - good reviews by staff and looks like a vibrant place to work = high retention of key staff and high motivation of staff
- Health and wellbeing is more and more important after covid – so likely biz will increase
- They paid out on ALL their covid claims - I think they can shout this out loud proudly (here's looking at you hiscox) - I think this will be remembered by their customers.

What's not to like at these prices!

- it seems that quite a few departments in law firms are doing very well given the planning of Brexit etc. So I believe the Nov lockdown had little to no negative impact on Rosenblatt.



FORGOTTEN STOCK

Like £CRL , £RGBP -

- got sold off big time and did not recover from the sell-off in mad October (the doom and gloom month)

- the vaccine jump, had no positive effect on it (and why should it given that more money was to be made from more visible covid-battered value stocks (plus fried chips on the side!) )

All this meant that SP has remained at a battered price of 59p (mid price).



Overall, I reckon £RBGP is an excellent opp for a contrarian play with minimal downside with short term possible upside of 15-20% (or medium term wise- 50%+ if £RGBP can get back to pre-covid SP (with Convex (who was acquired I believe late 2019) giving additional helping hand (however, you may need to balance this off with the potential dilution if Convex hits their targets and fulfils the earn-out clause)).

Yes it is not like £RR / or £IQAI, ie rollercoaster ride. However, if you are like me and like your ciggie butt plays, this could be a good'un! Usual caveats, dyor.

Just dipped my toes into £RBGP today. It's completely out of favour in the current market. However, when stocks are shunned, for the contrarians out there, this could be an excellent play. Trade Update is expected in late Jan or early Feb 21. Current spread circa < 2%.

SUPPORT LEVEL - I have been scrutinising the trades over the past weeks. Whilst it has not gone up, it has remained at a support level of 58p (asking price). From the SP chart, you can see that this price has provided support in the past.
Currently, this is nearing the trough, the ciggie butt and it has been there for weeks.
During the Brexit negotiations last week, £RBGP's SP stayed relatively unmoved.

OCT 20 TU - From https://www.investegate.co.uk/rbg-holdings-plc/rns/trading---market-guidance-update/202010060700061583B/
£RBGP had a positive update which showed
a/ Lionfish getting back on track
b/ Convex Capital - the company specialising in selling companies - contributing to £RBGP
c/ Law firm side - remains robust.
From similar starting levels, the SP shot up to circa 10% after the TU.

SIMON THOMPSON (ST) - Given the positive TU, ST wrote an article on £RGBP, which lead to the SP to rise to its Oct 20, from 65p (after the initial release of the positive TU) to a high of 69p. Given that this has been one of his picks, it is likely that ST may recommend £RGBP come early next year again.

INDIVIDUAL COMPANIES PERFORMANCE
a/ Lionfish - is involved with litigation financing. In 2020, £RGBP have been strenghthening this team with the appointment of a new head. Given the current climate, I would believe litigation financing is attractive for potential plaintiff companies and able to perform well in H2 and beyond.
b/ Convex Capital - with the possible changes in capital gains tax for entrepreneurs, this has spurred on entrepreneurs seeking to flog their businesses ASAP. See https://www.ft.com/content/0129ca54-bb8e-4b06-8afd-0ff7ccb2233d
Whilst Convex may not be on a same playing field in terms of size and diversity as £K3C, flogging companies is what Convex specialises in. In H1, they were pretty messed up with the lockdown. In H2, given the Chancellor's possible raid on CGT, I believe, Convex would be pretty busy despite Nov lockdown. Also Oct 20 TU, mentions that Convex aleady have sales in their kitty.
c/ Rosenblatt operation (law firm) - We know from the Oct 20 TU, Rosenblatt was doing pretty good.
"Following the publication of the Group's interim results for six months to 30 June 2020 on 16 September 2020, the Group's law firm, Rosenblatt Limited ("RBL") has continued to trade well with case value and volumes remaining significantly ahead year-on-year."
The question is how has / will Rosenblatt perform from 17th Sept to 31st Dec?
I believe that Rosenblatt have gone from strength to strength because a Cross read from £GTLY and £KEYS (particularly £KEYS who issued a recent TU on 30th Nov 20 stating that their performance was "comfortably ahead")

Hi GW2014, w.r.t freezers - I've been following with an avid interest. So far, it seems that the freezers are TwinGuard Series Ultra-Low Freezers which I believe are from another vendor. I say so far because this is based on the photos from the recent publicity in preparation for V-day.

Hey Hypermarlin
To identify whether u should get on the boat now or not - or whether the retracement is due to sell off in view of Brexit (altho. not affected with Brexit but shareholders may sell-off due to margin calls / overall market sentiment) - you may want to keep an eye out on Albemarle Corporation NYSE: ALB
If they are going up - infers more favourable entry into Li
Wiki - Albemarle Corporation is a fine chemical manufacturing company based in Charlotte, North Carolina. It operates 3 divisions: lithium, bromine specialties and catalysts. Albemarle is the largest provider of lithium for electric vehicle batteries.

EKF are exclusive distributors of this in UK and Germany + non-exclusive dis-r in other parts of Europe

https://www.med-technews.com/news/test-measuring-level-of-covid-19-neutralising-antibodies-lau/

Note EKF, (RENX (part of the JV producers of Kantaro kit), SourceBio (SBI) who are the lab guys who may get involved in the bloodworks of the Kantaro kit are all part of Christopher Mills stable, i.e. Harwood Capital.

The CEO was asked about the impact on Brexit during presentation of H1. He said something along the lines of minimal impact on RPS - but more so on their clients ( I assume he is referring to private clients and not the public sector). Where the Public sector is a client + water companies - Brexit has minimal impact. Furthermore, their revenue streams are quite geographically diversified anyway - so this Brexit fall = chance to buy in.

Stellar set of results!

Cross read from MPE
https://www.morningstar.co.uk/uk/news/AN_1607365657841784100/in-brief-mp-evans-notes-indonesian-government-change-to-export-levy.aspx

7 December, 2020
MP Evans Group PLC - producer of sustainable Indonesian palm oil - Says Indonesian government makes changes to its palm oil export levy, effective from Thursday.

"These increases had been widely anticipated in the market for some weeks and reflected in contracts for crude palm oil struck by the group," MP Evans notes.

Says the newly-announced tax increases the revenue available to the Indonesian government to implement its programme of "boosting production and consumption" of palm biodiesel.

MP Evans expects changes will have only "very limited" impact on the company's 2020 results and the longer-term prospects for both the palm oil sector and the group remain positive.

Current stock price: 640.00 pence

Year-to-date change: down 12%

By Lucy Heming; lucyheming@alliancenews.com

With SLP, never knew when to catch on the train - saw it tipped by Simon Thompson in its 40s. Yes, I think I will let it retrace. Oh blast, it keeps going! And now it's high 70s. Should I or should I not...then late last week stumble across THS. Surely ..am I missing something.. yeah it's a set up ...wait...no ..gosh these financials are good .....it really is this attractive! I'm in - bought some early morning.

Thank you kindly to Retied Banker for the gold stocks. Will dig around there.

ragnarlothbrok - brilliant breakdown - tqvm!

Hey Tiger. Tq so much for your detailed overview. Very much appreciated!

Found this stock via the Paul Hill interview. Pretty impressed by the opportunity it presents. Loads of money (no equity fundraising required) ; improved investor relations and better management of investor expectations ; B2b growth ; B2C about to explode once overseas travel is back on everyone's cards ; B2B2B - literally a new division and a nice revenue stream for them ; plenty of upside. I presume there is a seller admist. Once they are out of the way, I think this stock will fly in 2020.